Keyphrases
Phosphoinositide 3-kinase (PI3K)
100%
Frailty
100%
Kinase Inhibitor
100%
Neutrophil Dysfunction
100%
Neutrophils
44%
Older Adults
33%
Neutrophil Activation
22%
Chemotaxis
22%
Systemic Inflammation
22%
Frail Elderly
22%
United Kingdom
11%
Regression Analysis
11%
Health Status
11%
Therapeutic Target
11%
Improved Outcomes
11%
Neutrophil Chemotaxis
11%
Neutrophil Migration
11%
Phosphoinositol
11%
Age-associated
11%
Advanced Age
11%
Older Persons
11%
Grip Strength
11%
Old Community
11%
Stroop Test
11%
Charlson Comorbidity Index
11%
Community-dwelling Adults
11%
PI3K Inhibitor
11%
Frailty Index
11%
Functional Aging
11%
Medicine and Dentistry
Inositol Phosphate
100%
Frailty
100%
Phosphotransferase Inhibitor
100%
Neutrophil
100%
Infection
20%
Chemotaxis
20%
In Vitro
10%
Health Status
10%
Neutrophil Chemotaxis
10%
Hand Grip
10%
Charlson Comorbidity Index
10%
Stroop Test
10%
Community-Dwelling Older Adults
10%
Frailty Index
10%
Pharmacology, Toxicology and Pharmaceutical Science
Inositol Phosphate
100%
Frailty
100%
Phosphotransferase Inhibitor
100%
Infection
20%
Inflammation
20%
Comorbidity
10%
Health Status
10%
Immunology and Microbiology
Neutrophil
100%
Chemotaxis
20%
Systemic Inflammation
20%
Blood Plasma
10%
Health Status
10%
Neutrophil Chemotaxis
10%
Comorbidity
10%
Grip Strength
10%